Nantahala Capital Management - Q1 2019 holdings

$3.21 Billion is the total value of Nantahala Capital Management's 115 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 29.6% .

 Value Shares↓ Weighting
IWM BuyISHARES TRput$872,614,000
+40.8%
5,700,000
+23.1%
27.22%
+42.7%
XBI BuySPDR SERIES TRUSTput$158,445,000
+120.8%
1,750,000
+75.0%
4.94%
+123.8%
SGMS SellSCIENTIFIC GAMES CORPcall$113,645,000
-8.8%
5,565,400
-20.1%
3.54%
-7.5%
EXAS BuyEXACT SCIENCES CORPput$112,277,000
+60.3%
1,296,200
+16.8%
3.50%
+62.5%
CDXS SellCODEXIS INC$110,112,000
+0.7%
5,363,484
-18.1%
3.43%
+2.1%
QURE SellUNIQURE NV$90,590,000
+26.8%
1,518,690
-38.7%
2.83%
+28.6%
CVNA  CARVANA COcall$84,187,000
+77.5%
1,450,0000.0%2.63%
+80.0%
FCAU SellFIAT CHRYSLER AUTOMOBILES Ncall$84,200,000
-35.1%
5,670,000
-36.8%
2.63%
-34.2%
WRLD SellWORLD ACCEP CORP DEL$75,882,000
+0.0%
647,845
-12.7%
2.37%
+1.4%
QURE BuyUNIQURE NVcall$71,580,000
+125.8%
1,200,000
+9.1%
2.23%
+129.0%
THC SellTENET HEALTHCARE CORPcall$69,216,000
+35.7%
2,400,000
-19.3%
2.16%
+37.6%
LXFR SellLUXFER HOLDINGS PLC$64,992,000
+39.9%
2,601,749
-1.3%
2.03%
+41.7%
AABA SellALTABA INC$63,778,000
+27.6%
860,464
-0.3%
1.99%
+29.3%
THC SellTENET HEALTHCARE CORP$61,173,000
+44.3%
2,121,112
-14.2%
1.91%
+46.3%
ARQL SellARQULE INC$57,506,000
+71.5%
12,005,361
-0.8%
1.79%
+74.0%
VAC SellMARRIOTT VACTINS WORLDWID CO$57,288,000
+2.3%
612,705
-22.8%
1.79%
+3.7%
DXPE BuyDXP ENTERPRISES INC NEW$49,202,000
+54.0%
1,264,195
+10.1%
1.54%
+56.2%
QADA BuyQAD INCcl a$45,722,000
+15.3%
1,061,578
+5.2%
1.43%
+16.8%
RH BuyRH$44,210,000
+199.6%
429,434
+248.7%
1.38%
+203.7%
AKBA SellAKEBIA THERAPEUTICS INC$40,467,000
+44.5%
4,941,061
-2.4%
1.26%
+46.4%
HCA SellHCA HEALTHCARE INCput$39,114,000
-55.1%
300,000
-57.1%
1.22%
-54.5%
CVNA SellCARVANA COcl a$36,793,000
+27.9%
633,714
-28.0%
1.15%
+29.7%
IMXI BuyINTERNATIONAL MNY EXPRESS IN$36,177,000
+39.2%
3,102,698
+42.7%
1.13%
+41.0%
CASH BuyMETA FINL GROUP INC$35,419,000
+2.4%
1,799,727
+0.9%
1.10%
+3.9%
GDEN SellGOLDEN ENTMT INC$34,688,000
-14.3%
2,449,713
-3.1%
1.08%
-13.2%
RH SellRHcall$34,437,000
-57.6%
334,500
-50.7%
1.07%
-57.0%
PRTY SellPARTY CITY HOLDCO INC$31,349,000
-28.3%
3,948,242
-9.9%
0.98%
-27.3%
XELA BuyEXELA TECHNOLOGIES INC$28,066,000
-14.1%
8,402,887
+0.0%
0.88%
-13.0%
ONDK BuyON DECK CAP INC$27,996,000
+16.4%
5,165,238
+26.7%
0.87%
+18.0%
AFI SellARMSTRONG FLOORING INC$27,603,000
+13.7%
2,029,624
-1.0%
0.86%
+15.3%
DLB SellDOLBY LABORATORIES INC$26,554,000
+0.8%
421,693
-1.1%
0.83%
+2.1%
CZR SellCAESARS ENTMT CORPcall$24,601,000
+20.8%
2,831,000
-5.6%
0.77%
+22.3%
GTTN SellGTT COMMUNICATIONS INC$22,493,000
+7.2%
648,218
-26.9%
0.70%
+8.8%
ACER SellACER THERAPEUTICS INC$21,492,000
+18.2%
884,455
-2.1%
0.67%
+19.9%
AGLE BuyAEGLEA BIOTHERAPEUTICS INC$21,351,000
+12.8%
2,652,260
+4.9%
0.67%
+14.4%
TBBK BuyBANCORP INC DEL$21,017,000
+7.0%
2,601,148
+5.4%
0.66%
+8.6%
SPB NewSPECTRUM BRANDS HLDGS INC NE$20,332,000371,150
+100.0%
0.63%
CURO SellCURO GROUP HLDGS CORP$19,828,000
-29.5%
1,976,890
-33.3%
0.62%
-28.6%
JYNT BuyJOINT CORP$17,934,000
+91.0%
1,138,693
+0.9%
0.56%
+93.4%
SGMS SellSCIENTIFIC GAMES CORP$17,312,000
-13.7%
847,785
-24.5%
0.54%
-12.5%
CRHM SellCRH MEDICAL CORP$16,618,000
-17.0%
6,284,155
-3.8%
0.52%
-15.9%
ESTA BuyESTABLISHMENT LABS HLDGS INC$15,195,000
+11.7%
632,061
+27.4%
0.47%
+13.4%
BDSI BuyBIODELIVERY SCIENCES INTL IN$14,497,000
+43.3%
2,735,267
+0.1%
0.45%
+45.3%
HTZGQ SellHERTZ GLOBAL HLDGS INCcall$13,491,000
-43.8%
776,700
-55.8%
0.42%
-43.0%
PAR SellPAR TECHNOLOGY CORP$13,460,000
+11.1%
550,299
-1.2%
0.42%
+12.6%
RDNT NewRADNET INC$12,809,0001,033,827
+100.0%
0.40%
SellFALCON MINERALS CORP$12,727,000
+1.6%
1,439,794
-2.3%
0.40%
+3.1%
BPI SellBRIDGEPOINT ED INC$12,133,000
-26.3%
1,985,786
-15.5%
0.38%
-25.4%
NEOS  NEOS THERAPEUTICS INC$11,706,000
+58.2%
4,485,0000.0%0.36%
+60.1%
DHX  DHI GROUP INC$11,686,000
+59.9%
4,809,2530.0%0.36%
+61.8%
SIGA SellSIGA TECHNOLOGIES INC$10,821,000
-39.8%
1,800,514
-20.8%
0.34%
-38.9%
RC NewREADY CAP CORP$9,528,000649,469
+100.0%
0.30%
RFL BuyRAFAEL HLDGS INC$8,661,000
+92.5%
684,666
+20.6%
0.27%
+95.7%
FTAC NewFINTECH ACQUISITION CORP III$8,587,000842,730
+100.0%
0.27%
RMBL  RUMBLEON INCcl b$8,074,000
-8.2%
1,634,3500.0%0.25%
-7.0%
CBIO BuyCATALYST BIOSCIENCES INC$7,771,000
+15.2%
958,243
+12.0%
0.24%
+16.3%
TLYS SellTILLYS INCcl a$7,714,000
-0.2%
693,103
-2.7%
0.24%
+1.3%
LINC  LINCOLN EDL SVCS CORP$7,554,000
-3.1%
2,436,8050.0%0.24%
-1.7%
SSKN SellSTRATA SKIN SCIENCES INC$7,533,000
+4.7%
2,643,001
-4.5%
0.24%
+6.3%
SIC NewSELECT INTERIOR CONCEPTS INCcl a$7,494,000601,961
+100.0%
0.23%
APEN BuyAPOLLO ENDOSURGERY INC$7,146,000
+17.6%
1,910,562
+8.5%
0.22%
+19.3%
HTZGQ NewHERTZ GLOBAL HLDGS INC$6,948,000400,000
+100.0%
0.22%
ELVT SellELEVATE CREDIT INC$6,789,000
-4.2%
1,564,364
-1.1%
0.21%
-2.8%
CUE  CUE BIOPHARMA INC$6,788,000
+64.5%
878,0980.0%0.21%
+66.9%
IGT  INTERNATIONAL GAME TECHNOLOGcall$6,495,000
-11.2%
500,0000.0%0.20%
-9.8%
GLMD SellGALMED PHARMACEUTICALS LTD$6,493,000
+13.9%
794,701
-4.8%
0.20%
+16.0%
CEMI BuyCHEMBIO DIAGNOSTICS INC$6,383,000
+37.5%
1,150,000
+40.2%
0.20%
+39.2%
ENT SellGLOBAL EAGLE ENTMT INC$6,268,000
-68.3%
8,835,876
-0.2%
0.20%
-67.9%
MFCB  MFC BANCORP LTD$6,222,000
+41.3%
846,5550.0%0.19%
+43.7%
VIVE  VIVEVE MED INC$6,185,000
-10.5%
6,581,4650.0%0.19%
-9.4%
NATR  NATURES SUNSHINE PRODUCTS IN$5,421,000
+14.0%
583,5100.0%0.17%
+15.8%
INSUU NewINSURANCE ACQUISTION CORPunit 03/31/2024$5,050,000500,000
+100.0%
0.16%
ARYAU NewARYA SCIENCES ACQUISITION COunit 10/04/2023$4,688,000452,944
+100.0%
0.15%
SHOS  SEARS HOMETOWN & OUTLET STOR$4,540,000
-0.2%
2,136,2510.0%0.14%
+1.4%
PIRS  PIERIS PHARMACEUTICALS INC$4,550,000
+25.9%
1,358,1000.0%0.14%
+27.9%
DVD SellDOVER MOTORSPORTS INC$3,425,000
+6.2%
1,695,541
-1.2%
0.11%
+8.1%
TA SellTRAVELCENTERS AMER LLC$2,977,000
+4.3%
724,401
-4.6%
0.09%
+5.7%
EMMS SellEMMIS COMMUNICATIONS CORP$2,799,000
+6.8%
781,783
-4.9%
0.09%
+7.4%
DRIO  DARIOHEALTH CORP$2,470,000
-8.5%
3,350,9810.0%0.08%
-7.2%
RDNT NewRADNET INCcall$2,478,000200,000
+100.0%
0.08%
IOVA SellIOVANCE BIOTHERAPEUTICS INC$2,272,000
-40.0%
238,945
-44.1%
0.07%
-38.8%
MOTS  MOTUS GI HLDGS INC$1,950,000
+25.4%
500,0000.0%0.06%
+27.1%
FTDCQ  FTD COS INC$1,892,000
-65.5%
3,710,7630.0%0.06%
-65.1%
STRM  STREAMLINE HEALTH SOLUTIONS$1,848,000
+29.6%
1,760,2970.0%0.06%
+31.8%
ASCMA  ASCENT CAP GROUP INC$1,349,000
+88.9%
1,794,2600.0%0.04%
+90.9%
CHACU  CHARDAN HEALTHCARE ACQUISITIunit 12/13/2023$1,003,000
-0.4%
100,0000.0%0.03%0.0%
 FALCON MINERALS CORP*w exp 07/21/202$729,000
+38.3%
878,0220.0%0.02%
+43.8%
KIRK SellKIRKLANDS INCput$703,000
-85.2%
100,000
-80.0%
0.02%
-85.0%
RBCAA  REPUBLIC BANCORP KYcl a$330,000
+15.8%
7,3710.0%0.01%
+11.1%
NewAPTOSE BIOSCIENCES INC$125,00062,042
+100.0%
0.00%
FTDCQ NewFTD COS INCcall$128,000250,000
+100.0%
0.00%
RRTS ExitROADRUNNER TRNSN SVCS HLDG I$0-948,178
-100.0%
-0.02%
RLGT ExitRADIANT LOGISTICS INC$0-525,300
-100.0%
-0.07%
AKBA ExitAKEBIA THERAPEUTICS INCcall$0-414,000
-100.0%
-0.07%
DDE ExitDOVER DOWNS GAMING & ENTMT I$0-1,161,233
-100.0%
-0.10%
GAIA ExitGAIA INC NEWcl a$0-443,698
-100.0%
-0.14%
ARYA ExitARYA SCIENCES ACQUISITION CO$0-452,944
-100.0%
-0.14%
FLWS ExitFLWS/1-800 FLOWERScl a$0-509,217
-100.0%
-0.19%
CCXI ExitCHEMOCENTRYX INC$0-623,338
-100.0%
-0.21%
FTACU ExitFINTECH ACQUISITION CORP IIIunit 12/01/2023$0-842,730
-100.0%
-0.26%
SCVL ExitSHOE CARNIVAL INCput$0-269,900
-100.0%
-0.28%
GME ExitGAMESTOP CORP NEWcl a$0-731,500
-100.0%
-0.28%
GM ExitGENERAL MTRS COput$0-300,000
-100.0%
-0.31%
ORM ExitOWENS RLTY MTG INC$0-603,282
-100.0%
-0.35%
OZK ExitBANK OZK$0-500,000
-100.0%
-0.35%
HRB ExitBLOCK H & R INCput$0-800,000
-100.0%
-0.62%
SPY ExitSPDR S&P 500 ETF TRput$0-250,000
-100.0%
-1.92%
IWM ExitISHARES TRcall$0-1,552,600
-100.0%
-6.40%
IYR ExitISHARES TRput$0-3,000,000
-100.0%
-6.92%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-15
Signatures

The EDGAR filing(s) were signed by:

About Nantahala Capital Management

Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.

Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.

Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.

Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR42Q3 202327.2%
CODEXIS INC42Q3 20233.9%
PATHWARD FINANCIAL INC35Q3 20236.3%
SCIENTIFIC GAMES CORP34Q3 20225.3%
DOVER MOTORSPORTS INC34Q3 20210.5%
GOLDEN ENTMT INC33Q3 20232.1%
QAD INC32Q3 20212.6%
SCIENTIFIC GAMES CORP31Q4 20217.7%
DOLBY LABORATORIES INC31Q4 20205.6%
LINCOLN EDL SVCS CORP31Q4 20210.7%

View Nantahala Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Nantahala Capital Management Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AYTU BIOPHARMA, INCJune 16, 20231,086,81219.7%
Acer Therapeutics Inc.February 14, 20231,226,1917.5%
Aeglea BioTherapeutics, Inc.February 14, 20234,611,3027.5%
AKUMIN INC.February 14, 20232,206,9602.5%
ALTA EQUIPMENT GROUP INC.February 14, 20231,188,9853.7%
Apollo Endosurgery, Inc.February 14, 20234,056,6279.9%
Autolus Therapeutics plcFebruary 14, 20237,782,0184.7%
Bioventus Inc.February 14, 20233,168,5745.1%
CATALYST BIOSCIENCES, INC.February 14, 2023438,0551.4%
Drive Shack Inc.February 14, 20236,500,0007.0%

View Nantahala Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-21
42024-03-15
SC 13G2024-03-11
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Nantahala Capital Management's complete filings history.

Compare quarters

Export Nantahala Capital Management's holdings